The Latest Cardiac and Vascular News
(GLOBE NEWSWIRE via COMTEX) —The Onyx ONE Clear Study Builds Upon Body of Clinical Evidence to Inform Individualized DAPT Duration Following Stent Procedures DUBLIN – September 10, 2018 – Medtronic plc (NYSE:MDT) today announced the start of the Onyx ONE Clear Study in the U.S. and Japan that will evaluate one-month […]
(GLOBE NEWSWIRE via COMTEX) –DUBLIN – September 4, 2018 – Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the Morgan Stanley 16th Annual Global Healthcare Conference on Friday, September 14, 2018, in New York City. Karen Parkhill, executive vice president and chief financial officer […]
BURLINGTON, Mass., Sept. 07, 2018 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be presenting at four conferences in September. David Roberts, President, will participate in the Lake Street Best Ideas Growth Conference on Thursday, September 13, 2018 at the Parker Hotel in New York City. […]
IRVING, Texas–(BUSINESS WIRE)–Vizient, Inc. today released its report “The Beat Goes On: Weighing Clinical Benefits, Patient Selection and Healthcare Economics of MRI-Compatible Cardiac Rhythm Devices”, which discusses the financial impact to hospitals resulting from the sudden and dramatic increase in the use of MRI-compatible CRM devices over the last 18 months. Magnetic resonance imaging (MRI)-compatible […]
KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a leading U.S. developer of wearable biosensors and diagnostic software systems featuring proprietary automated data analysis algorithms, announced today that its wearable ECG Sensor, Cardea SOLO, continues to attract high-volume cardiology group practices across the U.S. The company unveiled Baltimore Heart Associates of Maryland (www.baltimoreheart.com) […]
MILAN, Italy, Sept. 6, 2018 /PRNewswire/ — InnovHeart s.r.l., a privately-held, venture-backed developer of transcatheter-delivered mitral valve replacement systems (TMVR) for the treatment of mitral valve disease, announced today that it has appointed veteran medical device executive Keith D. Dawkins, M.D., as Chairman of its Board of Directors. Dr. Dawkins is transitioning from his […]
PETAH TIKVA, Israel, Sept. 6 2018 /PRNewswire/ — Leviticus Cardio, inventors of the versatile transcutaneous Coplanar Energy Transfer (CET) system for use with implanted left ventricular assist devices (LVADs), announces the successful completion of a 90-day preclinical chronic animal study to evaluate its CET technology in combination with a commercial heart pump. The […]
FLAGSTAFF, Ariz.–(BUSINESS WIRE)–W. L. Gore & Associates, Inc. (Gore) has completed enrollment for the pivotal phase of the Gore ASSURED Clinical Study. This investigational device exemption (IDE) trial is researching the new GORE®CARDIOFORM ASD Occluder for the interventional closure of Atrial Septal Defects (ASDs), sized 8 to 35 mm. The […]
SAN JOSE, Calif., Sept. 5, 2018 /PRNewswire/ — A&D Medical, a global leader in connected health and biometric measurement devices and services, today announced its line of ULTRACONNECT blood pressure monitors is available nationwide, giving patients who are managing hypertension a new tool to better manage their heart health – with just a twist […]
REDWOOD CITY, Calif., Sept. 05, 2018 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it is developing “Biopatch,” an ECG patch which it hopes to release in Q1 2019. An extension of the company’s award-winning Bioflux device, Biopatch offers an alternative to the 3-lead system […]
